Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Briacell Therapeutics Corp 235 15th Street Suite 300 WEST VANCOUVER A1 V7T 2X1 CAN

www.briacell.com P: 604-921-1810 F: 424-245-3719

Description:

BriaCell Therapeutics Corp. is an immuno-oncology focused biotechnology company. It developed a patented whole-cell vaccine, cancer immunotherapy technology called the `BriaVax` vaccine for cancer. The company's technology consists of Bria-IMT(TM), Bria-OTS(TM) and BriaDx(TM) which are in clinical stage. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 17,883
Enterprise Value, $K -3,367
Shares Outstanding, K 18,285
Annual Sales, $ 0 K
Annual Net Income, $ -20,300 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ 1,720 K
EBIT, $ -35,270 K
EBITDA, $ -35,250 K
60-Month Beta 1.29
% of Insider Shareholders 21.77%
% of Institutional Shareholders 15.42%
Float, K 14,304
% Float 78.23%
Short Volume Ratio 0.54

Growth:

1-Year Return -85.54%
3-Year Return -78.02%
5-Year Return -95.16%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 85.70%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.11 on 06/14/24
Next Earnings Date 06/12/24
Earnings Per Share ttm -1.25
EPS Growth vs. Prev Qtr 115.49%
EPS Growth vs. Prev Year 134.38%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-300 on 01/02/20

BCTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -37.35%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.39
Interest Coverage -1.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar